As of today we have preliminary prints on “Elsevier“:
The efficacy of ChAdOx1 nCoV-19 against the B.1.1.7 variant of SARS-CoV-2 is similar to the efficacy of the vaccine against other lineages. Furthermore, vaccination with ChAdOx1 nCoV-19 results in a reduction in the duration of shedding and viral load, which may translate into a material impact on the transmission of disease.
Translation: No, the Covid 19 Variants are not a problem. For Astra Zeneca vaccine at least.
Please proceed to the original article …